Benjamin Hickey - 13 Dec 2023 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
EVP, Chief Commercial Officer
Signature
/s/ John Moriarty, Attorney-in-Fact
Issuer symbol
MRTX
Transactions as of
13 Dec 2023
Transactions value $
-$125,807
Form type
4
Filing time
14 Dec 2023, 17:05:02 UTC
Previous filing
07 Nov 2023
Next filing
18 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$125,807 -2,220 -2.1% $56.67 103,694 13 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the performance stock units (PSUs) granted on June 25, 2021.